{"title":"在一种新的小鼠模型中,胆碱能神经元中严重的动力蛋白功能障碍会加剧类似渐冻人症的表型。","authors":"Fabio A. Simoes , Eleni Christoforidou , Raphaelle Cassel , Luc Dupuis , Majid Hafezparast","doi":"10.1016/j.bbadis.2024.167540","DOIUrl":null,"url":null,"abstract":"<div><div>Cytoplasmic dynein 1, a motor protein essential for retrograde axonal transport, is increasingly implicated in the pathogenesis of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS). In this study, we developed a novel mouse model that combines the <em>Legs at odd angles</em> (<em>Loa</em>, F580Y) point mutation in the dynein heavy chain with a cholinergic neuron-specific knockout of the dynein heavy chain. This model, for the first time, allows us to investigate the impact of <em>Loa</em> allele exclusivity in these neurons into adulthood. Our findings reveal that this selective increase in dynein dysfunction exacerbated the phenotypes observed in heterozygous <em>Loa</em> mice including pre-wean survival, reduced body weight and grip strength. Additionally, it induced ALS-like pathology in neuromuscular junctions (NMJs) not seen in heterozygous <em>Loa</em> mice. Notably, we also found a previously unobserved significant increase in neurons displaying TDP-43 puncta in both <em>Loa</em> mutants, suggesting early TDP-43 mislocalisation – a hallmark of ALS. The novel model also exhibited a concurrent rise in p62 puncta that did not co-localise with TDP-43, indicating broader impairments in autophagic clearance mechanisms. Overall, this new model underscores the fact that dynein impairment alone can induce ALS-like pathology and provides a valuable platform to further explore the role of dynein in ALS.</div></div>","PeriodicalId":8821,"journal":{"name":"Biochimica et biophysica acta. Molecular basis of disease","volume":null,"pages":null},"PeriodicalIF":4.2000,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Severe dynein dysfunction in cholinergic neurons exacerbates ALS-like phenotypes in a new mouse model\",\"authors\":\"Fabio A. Simoes , Eleni Christoforidou , Raphaelle Cassel , Luc Dupuis , Majid Hafezparast\",\"doi\":\"10.1016/j.bbadis.2024.167540\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Cytoplasmic dynein 1, a motor protein essential for retrograde axonal transport, is increasingly implicated in the pathogenesis of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS). In this study, we developed a novel mouse model that combines the <em>Legs at odd angles</em> (<em>Loa</em>, F580Y) point mutation in the dynein heavy chain with a cholinergic neuron-specific knockout of the dynein heavy chain. This model, for the first time, allows us to investigate the impact of <em>Loa</em> allele exclusivity in these neurons into adulthood. Our findings reveal that this selective increase in dynein dysfunction exacerbated the phenotypes observed in heterozygous <em>Loa</em> mice including pre-wean survival, reduced body weight and grip strength. Additionally, it induced ALS-like pathology in neuromuscular junctions (NMJs) not seen in heterozygous <em>Loa</em> mice. Notably, we also found a previously unobserved significant increase in neurons displaying TDP-43 puncta in both <em>Loa</em> mutants, suggesting early TDP-43 mislocalisation – a hallmark of ALS. The novel model also exhibited a concurrent rise in p62 puncta that did not co-localise with TDP-43, indicating broader impairments in autophagic clearance mechanisms. Overall, this new model underscores the fact that dynein impairment alone can induce ALS-like pathology and provides a valuable platform to further explore the role of dynein in ALS.</div></div>\",\"PeriodicalId\":8821,\"journal\":{\"name\":\"Biochimica et biophysica acta. Molecular basis of disease\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.2000,\"publicationDate\":\"2024-10-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biochimica et biophysica acta. Molecular basis of disease\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0925443924005349\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochimica et biophysica acta. Molecular basis of disease","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0925443924005349","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
细胞质动力蛋白 1 是一种对轴突逆行运输至关重要的运动蛋白,它与肌萎缩性脊髓侧索硬化症(ALS)等神经退行性疾病的发病机制有越来越密切的联系。在这项研究中,我们开发了一种新型小鼠模型,该模型结合了动力蛋白重链中的 Legs at odd angles(Loa,F580Y)点突变和胆碱能神经元特异性动力蛋白重链敲除。这一模型首次允许我们研究 Loa 等位基因排他性对这些神经元成年期的影响。我们的研究结果表明,这种选择性增加的动力蛋白功能障碍加剧了在杂合子 Loa 小鼠中观察到的表型,包括断奶前存活率、体重和握力下降。此外,它还诱导了神经肌肉接头(NMJ)出现类似 ALS 的病理变化,这在杂合子 Loa 小鼠中是看不到的。值得注意的是,我们还发现,在两种 Loa 突变体中,显示 TDP-43 点的神经元数量显著增加,这是以前未曾观察到的,这表明 TDP-43 早期错定位--这是 ALS 的一个特征。这种新型模型还表现出与 TDP-43 并不共定位的 p62 点同时增加,这表明自噬清除机制出现了更广泛的损伤。总之,这种新模型强调了这样一个事实,即单靠动力蛋白损伤就能诱发类似渐冻人症的病理变化,并为进一步探索动力蛋白在渐冻人症中的作用提供了一个宝贵的平台。
Severe dynein dysfunction in cholinergic neurons exacerbates ALS-like phenotypes in a new mouse model
Cytoplasmic dynein 1, a motor protein essential for retrograde axonal transport, is increasingly implicated in the pathogenesis of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS). In this study, we developed a novel mouse model that combines the Legs at odd angles (Loa, F580Y) point mutation in the dynein heavy chain with a cholinergic neuron-specific knockout of the dynein heavy chain. This model, for the first time, allows us to investigate the impact of Loa allele exclusivity in these neurons into adulthood. Our findings reveal that this selective increase in dynein dysfunction exacerbated the phenotypes observed in heterozygous Loa mice including pre-wean survival, reduced body weight and grip strength. Additionally, it induced ALS-like pathology in neuromuscular junctions (NMJs) not seen in heterozygous Loa mice. Notably, we also found a previously unobserved significant increase in neurons displaying TDP-43 puncta in both Loa mutants, suggesting early TDP-43 mislocalisation – a hallmark of ALS. The novel model also exhibited a concurrent rise in p62 puncta that did not co-localise with TDP-43, indicating broader impairments in autophagic clearance mechanisms. Overall, this new model underscores the fact that dynein impairment alone can induce ALS-like pathology and provides a valuable platform to further explore the role of dynein in ALS.
期刊介绍:
BBA Molecular Basis of Disease addresses the biochemistry and molecular genetics of disease processes and models of human disease. This journal covers aspects of aging, cancer, metabolic-, neurological-, and immunological-based disease. Manuscripts focused on using animal models to elucidate biochemical and mechanistic insight in each of these conditions, are particularly encouraged. Manuscripts should emphasize the underlying mechanisms of disease pathways and provide novel contributions to the understanding and/or treatment of these disorders. Highly descriptive and method development submissions may be declined without full review. The submission of uninvited reviews to BBA - Molecular Basis of Disease is strongly discouraged, and any such uninvited review should be accompanied by a coverletter outlining the compelling reasons why the review should be considered.